tetano
Editor, Senior Moderator
Cells
. 2021 Nov 9;10(11):3098.
doi: 10.3390/cells10113098.
In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity
Sara H A Agwa[SUP] 1 [/SUP], Hesham Elghazaly[SUP] 2 [/SUP], Mahmoud Shawky El Meteini[SUP] 3 [/SUP], Sherif M Shawky[SUP] 1 4 5 [/SUP], Marwa Ali[SUP] 6 [/SUP], Aya M Abd Elsamee[SUP] 7 [/SUP], Safa Matbouly Sayed[SUP] 8 [/SUP], Nadine Sherif[SUP] 6 [/SUP], Howida M Sharaf[SUP] 9 [/SUP], Mohamed A Alhadidy[SUP] 10 [/SUP], Marwa Matboli[SUP] 1 6 [/SUP]
Affiliations
Abstract
(1) Background: The coronavirus (COVID-19) pandemic is still a major global health problem, despite the development of several vaccines and diagnostic assays. Moreover, the broad symptoms, from none to severe pneumonia, and the various responses to vaccines and the assays, make infection control challenging. Therefore, there is an urgent need to develop non-invasive biomarkers to quickly determine the infection severity. Circulating RNAs have been proven to be potential biomarkers for a variety of diseases, including infectious ones. This study aimed to develop a genetic network related to cytokines, with clinical validation for early infection severity prediction. (2) Methods: Extensive analyses of in silico data have established a novel IL11RA molecular network (IL11RNA mRNA, LncRNAs RP11-773H22.4 and hsa-miR-4257). We used different databases to confirm its validity. The differential expression within the retrieved network was clinically validated using quantitative RT-PCR, along with routine assessment diagnostic markers (CRP, LDH, D-dimmer, procalcitonin, Ferritin), in100 infected subjects (mild and severe cases) and 100 healthy volunteers. (3) Results: IL11RNA mRNA and LncRNA RP11-773H22.4, and the IL11RA protein, were significantly upregulated, and there was concomitant downregulation of hsa-miR-4257, in infected patients, compared to the healthy controls, in concordance with the infection severity. (4) Conclusion: The in-silico data and clinical validation led to the identification of a potential RNA/protein signature network for novel predictive biomarkers, which is in agreement with ferritin and procalcitonin for determination of COVID-19 severity.
Keywords: COVID-19 infection potential biomarker; IL11RA protein overexpression; SARS-COV-2 infection severity prediction; bioinformatics; circulating RNAs; coding and non-coding RNAs; interleukins genetic network.
. 2021 Nov 9;10(11):3098.
doi: 10.3390/cells10113098.
In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity
Sara H A Agwa[SUP] 1 [/SUP], Hesham Elghazaly[SUP] 2 [/SUP], Mahmoud Shawky El Meteini[SUP] 3 [/SUP], Sherif M Shawky[SUP] 1 4 5 [/SUP], Marwa Ali[SUP] 6 [/SUP], Aya M Abd Elsamee[SUP] 7 [/SUP], Safa Matbouly Sayed[SUP] 8 [/SUP], Nadine Sherif[SUP] 6 [/SUP], Howida M Sharaf[SUP] 9 [/SUP], Mohamed A Alhadidy[SUP] 10 [/SUP], Marwa Matboli[SUP] 1 6 [/SUP]
Affiliations
- PMID: 34831321
- DOI: 10.3390/cells10113098
Abstract
(1) Background: The coronavirus (COVID-19) pandemic is still a major global health problem, despite the development of several vaccines and diagnostic assays. Moreover, the broad symptoms, from none to severe pneumonia, and the various responses to vaccines and the assays, make infection control challenging. Therefore, there is an urgent need to develop non-invasive biomarkers to quickly determine the infection severity. Circulating RNAs have been proven to be potential biomarkers for a variety of diseases, including infectious ones. This study aimed to develop a genetic network related to cytokines, with clinical validation for early infection severity prediction. (2) Methods: Extensive analyses of in silico data have established a novel IL11RA molecular network (IL11RNA mRNA, LncRNAs RP11-773H22.4 and hsa-miR-4257). We used different databases to confirm its validity. The differential expression within the retrieved network was clinically validated using quantitative RT-PCR, along with routine assessment diagnostic markers (CRP, LDH, D-dimmer, procalcitonin, Ferritin), in100 infected subjects (mild and severe cases) and 100 healthy volunteers. (3) Results: IL11RNA mRNA and LncRNA RP11-773H22.4, and the IL11RA protein, were significantly upregulated, and there was concomitant downregulation of hsa-miR-4257, in infected patients, compared to the healthy controls, in concordance with the infection severity. (4) Conclusion: The in-silico data and clinical validation led to the identification of a potential RNA/protein signature network for novel predictive biomarkers, which is in agreement with ferritin and procalcitonin for determination of COVID-19 severity.
Keywords: COVID-19 infection potential biomarker; IL11RA protein overexpression; SARS-COV-2 infection severity prediction; bioinformatics; circulating RNAs; coding and non-coding RNAs; interleukins genetic network.